Finance

Beta
Roʻyxatlar
Aksiyalar sektorlari
Belgilar
Belgilar
Narxi
Oʻzgartirishlar
Dinamika (%)
Trend
Avvalgi yopilish narxi
Ochish
Yuqori
Past
Hajmi
Bozor kapitali
SIXB
Materials
SIXB
Materials
SIXB
+0,25%
1 104,10
+2,73
+0,25%
—1 101,371 103,631 105,311 091,41——
SIXC
Communications
SIXC
Communications
SIXC
-1,50%
604,16
-9,19
-1,50%
—613,35613,35613,35601,49——
SIXE
Energy
SIXE
Energy
SIXE
-0,09%
1 197,81
-1,02
-0,09%
—1 198,831 199,681 199,751 182,41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,88%
1 740,41
-15,54
-0,88%
—1 755,951 754,061 756,031 734,69——
SIXM
Financials
SIXM
Financials
SIXM
-0,64%
634,44
-4,07
-0,64%
—638,51637,41637,41633,05——
SIXR
Staples
SIXR
Staples
SIXR
-0,31%
840,90
-2,62
-0,31%
—843,52843,35846,40837,93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,38%
215,13
-0,82
-0,38%
—215,95215,95216,84215,06——
SIXT
Technology
SIXT
Technology
SIXT
+2,86%
3 228,71
+89,80
+2,86%
—3 138,913 189,303 230,853 174,76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,16%
935,87
+1,50
+0,16%
—934,37934,72938,26927,50——
SIXV
Health care
SIXV
Health care
SIXV
-1,37%
1 457,12
-20,31
-1,37%
—1 477,431 474,121 474,121 451,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,83%
2 399,84
+19,65
+0,83%
—2 380,192 389,342 403,042 380,47——
CTSO:NASDAQ
Cytosorbents Corp
0,63 US$
-3,04%
(-0,020) 1K
24-apr, 16:00:01 (GMT-4)  ·   USD
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
CTSO tikeri uchun statistika yaratilmoqda...
Ochish
0,64 US$
Yuqori
0,65 US$
Past
0,62 US$
Bozor kapitali
39,26 mln
Oʻrtacha hajm
99,75 ming
Hajmi
22,06 ming
52 haftalik eng yuqori
1,39 US$
52 haftalik eng past
0,50 US$
Aksiya boʻyicha daromad
-0,13 US$
Beta
1,47
Muomaladagi aksiyalar
62,80 mln
Xodimlar soni
129
Yangiliklar
Internetdagi manbalardan
Profil
CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey. CytoSorbents sells a cytokine adsorbing column — a blood purification technology based on porous polymer beads that act like sponges in an attempt to remove harmful inflammatory mediators like Cytokines, Bilirubin, Myoglobin from the blood. The use of hemoperfusion columns is generally limited to patients who are critically ill in high-resource counties, and they require a patient to be connected to a hemofiltration system such as Dialysis, Hemofiltration Cardiopulmonary bypass or ECMO. Other blood purification devices are using different technologies with different performance parameters. This is including polymyxin B hemoperfusion columns, which failed to show significance in a clinical trial for sepsis. The CytoSorb technology has actually the largest body of clinical data confirming safety and efficacy. Clinicaltrials.gov is giving an overview over running research projects. CytoSorbents was awarded a $3.8 million contract by Defense Advanced Research Projects Agency for its “Dialysis-Like Therapeutics” program to treat sepsis by removing cytokines and pathogen-derived toxins. Wikipedia
Cytosorbents Corp haqida
CEO-
Xodimlar soni129
Asos solingan1997
Bosh ofislar-
Sektor-
Veb-saytcytosorbents.com
Avvalgi hisobotlarBarcha qiymatlar – USD
Loading Previous Earnings...
Daromad hisoboti
Daromad
Sof foyda
Barcha qiymatlar – USD
mar, 2025
iyn, 2025
sen, 2025
dek, 2025
Daromad
8,73 mln
9,62 mln
9,48 mln
9,23 mln
Sotilgan mahsulotning tannarxi
2,52 mln
2,80 mln
2,82 mln
2,43 mln
Daromad narxi
2,52 mln
2,80 mln
2,82 mln
2,43 mln
Tadqiqot va ishlanmalarga xarajatlar
1,66 mln
1,26 mln
918,00 ming
1,24 mln
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
8,43 mln
9,17 mln
8,41 mln
9,61 mln
Operatsion xarajatlar
10,09 mln
10,43 mln
9,33 mln
10,86 mln
Jami operatsion xarajatlar
12,61 mln
13,23 mln
12,15 mln
13,28 mln
Operatsion daromad
-3,89 mln
-3,62 mln
-2,66 mln
-4,05 mln
Boshqa nooperatsion daromad
-
-
-
-
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
-1,48 mln
1,95 mln
-3,57 mln
-5,50 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
-1,48 mln
1,95 mln
-3,37 mln
-4,60 mln
Daromad soligʻi boʻyicha xarajat
-
-
-401,00 ming
-
Amaldagi soliq stavkasi
-
-
11,23%
-
Boshqa operatsion xarajatlar
-
-
-
-
Sof foyda
-1,48 mln
1,95 mln
-3,17 mln
-5,50 mln
Sof foyda marjasi
-16,94%
20,25%
-33,42%
-59,53%
Har bir aksiya foydasi
-
-
-
-
Foizlar va investitsiyalardan olingan daromadlar
-
-
-
-
Foizlarni toʻlash xarajatlari
-605,13 ming
-616,00 ming
-645,00 ming
-746,00 ming
Foizlarni toʻlash boʻyicha sof xarajatlar
-605,13 ming
-616,00 ming
-645,00 ming
-746,00 ming
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
-3,52 mln
-3,21 mln
-2,30 mln
-3,69 mln
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish

Tahlil

Vazifalarim
Hali vazifa yaratmagansiz
Vazifalaringiz shu yerda chiqadi. Vazifalarni rejalashtiring va Google Finance xizmatidan foydalaning.
Andozalar
Kuzatuv roʻyxati brifingi
Kuzatuv roʻyxatining kunlik bozor oldidan tahlili
Kelgusi tushumlar
Hafta ichida kelgusi tushum hisobotlari
Anomal volatillik va hajm
Bugun erta ogohlantirish: volatillik va hajm
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish